Noted: Kieran Furlong with Discovery to Product is also a partner with Finistere Ventures, where he makes venture capital investment decisions. Furlong appeared on the Salt of the Earth podcast to share insights on criteria …
News
UW-Madison spinoff Atrility’s device improves pediatric heart rhythm monitoring
The mother of invention visited Nicholas Von Bergen while he was caring for a newborn in the pediatric intensive care unit at American Family Children’s Hospital. Without the recent heart surgery, the infant faced a …
UW alum masterminding next generation data storage: A solution to the datapocalypse?
CATALOG, a Boston company co-founded by a recent UW–Madison Ph.D., is preparing to demonstrate the world’s fastest, densest DNA-based data-warehouse.
Isomark test detects infections two days before formal diagnosis
Noted: A device from Madison-based startup Isomark has been shown to detect infections two days before they could be diagnosed in a clinical setting. The study was conducted at four clinical sites, including UW-Madison, where …
NIH redoubling support in search for new antibiotics
The National Institutes of Health is redoubling support for UW-Madison researchers scouring the world for new sources of antibiotics. This comes as more than two million drug-resistant infections are reported every year, according to the …
A health-minded business accelerator program debuts
Noted: Thomas “Rock” Mackie has been named to lead the new Isthmus Project, a new accelerator on the UW-Madison campus that is designed to move inventions specifically from UW Health or the UW School of …
What $1M in Bay Area Startup Dollars Buys You in 12 Other Cities
Noted: Raising $1,000,000 of startup funding in San Francisco, California will buy you $1,421,613 of purchasing power if the startup is based in Madison, Wisconsin. Read the full article at: https://universityresearchpark.org/2019/what-1m-in-bay-area-startup-dollars-buys-you-in-12-other-cities/
WARF bets big on new squad of drug hunters
Noted: WARF Therapeutics, unveiled last week at a meeting on campus, will help UW–Madison investigators deal with a difficult reality: Pharmaceutical companies are reluctant to license newly discovered biological entities (more commonly called “targets”), such …
Making drugs more effective: Madison startup Dianomi Therapeutics draws a $3 million investment
Noted: Based on research from the lab of UW-Madison biomedical engineering professor Bill Murphy, Dianomi says it has devised a way to make medications that attack the source of pain — rather than the pain …